The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new warnings to antidepressants about unproven ...
The FDA grants Priority Review to brepocitinib for dermatomyositis after trial results show significant muscle and skin improvements in patients.
Atlanta Braves outfielder Jurickson Profar has been suspended for the 2026 season by Major League Baseball following his ...
Share on Pinterest A major review has found that the majority of statin side effects are not scientifically backed. Image Credit: BSIP/Getty Images Most statin side effects listed on drug packaging ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Adam Feuerstein is a senior ...
Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...
News-Medical.Net on MSN
How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday. The move is the latest sign that the FDA, under Health Secretary Robert F.
Once used by vets to anesthetize elephants, carfentanil is now an extremely dangerous illicit drug often disguised as an oxycodone tablet—and it's 100 times stronger than fentanyl.
President Trump's new TrumpRx online platform is a key part of his plan to help lower drug costs for consumers, with some polls showing two-thirds of Americans report high health care costs as their ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
Coverage of high-cost drugs selected for Medicare price negotiation has improved under the Inflation Reduction Act, according to an analysis from KFF. All Medicare Part D enrollees now have coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results